The very fact that a continuing medical education activity is commercially supported has to induce a greater perception of bias in the content, right? That’s something that has been taken as a given in everything from the Senate Finance Committee...
The healthcare reform bill that passed the House on March 21 with a 219-212 majority aims to change not only healthcare delivery in the United States, but also the reporting requirements for payments between pharmaceutical and medical-device...
Connecticut is considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction.
It's time to map out a plan of action we can use to overcome some of the challenges we face.
